Avedro Announces FDA Priority Review Status for Corneal Cross-linking New ... Fort Mills Times Patients with these sight threatening conditions may require corneal transplant surgery. If approved, riboflavin ophthalmic solution/KXL system would be the first FDA approved therapeutic treatment for these orphan indications. “US ophthalmic surgeons ... |
